The board meeting for Axsome Therapeutics Inc is scheduled for today, for the purpose of Axsome Therapeutics Inc First Quarter Earnings Results for 2026See details
Axsome Therapeutics Inc has a share price target of US$ 267, revenue growth forecast of 54.4%, and profit growth estimate of 38.1% for FY26, based on top 21 analyst calls.